News | January 06, 2008

HealthHelp Provides Imaging Services for High-Risk Plaque Study

January 7, 2008 - Imaging for early cardiovascular disease that causes heart attack and stroke is the focus of the High-Risk Plaque (HRP) Initiative, a new study to develop improved techniques for identifying individuals at risk for heart attacks and of advanced methods to monitor disease progression and treatment response.

The HRP Initiative, formed by Merck, AstraZeneca, Philips Medical Systems and BG Medicine, has recenlty added HealthHelp to coordinate national and market-specific clinical investigators, create safety processes and review patient images for incidental findings as part of HRP’s BioImage Study.

The BioImage Study aims to recruit approximately 7,300 asymptomatic patients with risk factors for HRP, stroke and heart disease to undergo blood tests and advanced imaging studies including ultrasound, CTs and MRIs. One of the initiative's primary goals is to determine the correlation between imaging and blood biomarkers and three-year heart-attack/stroke rates.

CT, MRI and ultrasound scans will be performed in investigational clinics established by BG Medicine in Chicago, Louisville and Miami. Radiological clinical investigators will oversee patient scanning and safety throughout the study. HealthHelp will also serve as a liaison between BG Medicine and NightHawk Radiology Services, which will be responsible for reading the scans for incidental findings that might affect patients' health.

HealthHelp has recruited the following prominent physicians to serve as clinical investigators for the BioImage Study:

Ebrahim S. Delpassand, M.D., chairman and director of Excel
Diagnostics Imaging Clinics in Houston
James T. Bui, M.D., assistant professor of radiology,
University of Illinois at Chicago
Albert Seow, M.D., professor of radiology, University of
Louisville School of Medicine
Hermes J. Florez, M.D., MPH, Ph.D., assistant professor of
clinical medicine, University of Miami Miller School of Medicine

For more information: www.healthhelp.com

Related Content

A comparison of CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockages and the correspending FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention.

A comparison of a CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockage and the corresponding FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention. Image courtesy of Kavitha Chinnaiyan, William Beaumont Hospital.

Feature | CT Angiography (CTA) | July 23, 2018 | Dave Fornell, Editor
The use of non-invasive fractional flow reserve CT (FFR-CT) was the hottest topic discussed at the Society of Cardiov
Videos | CT Angiography (CTA) | July 19, 2018
Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine,
Videos | CT Angiography (CTA) | July 18, 2018
A discussion with Gianluca Pontone, M.D., Ph.D., FSCCT, director of cardiovascular MRI, Centro Cardiologico Manzino,
Videos | CT Angiography (CTA) | July 17, 2018
A discussion with Todd Villines, M.D., FACC, FAHA, FSCCT, cardiologist, Georgetown Medical Center, and president of t
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | CT Angiography (CTA) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
iSchemaView Receives FDA Clearance for Rapid CTA
Technology | CT Angiography (CTA) | May 01, 2018
Cerebrovascular imaging analysis company iSchemaView received final clearance from the U.S. Food and Drug...
The use of metal artifact reduction software on this CCTA (CTA) cardiac CT from an Canon, Toshiba, Aquilion Precision, allows clear visualization inside a coronary stent. The 0.25 mm high-resolution reconstruction also helps delineate the various components of plaque.

The use of metal artifact reduction software on this Aquilion Precision image allows clear visualization inside a coronary stent. The 0.25 mm high-resolution reconstruction also helps delineate the various components of plaque.

Feature | CT Angiography (CTA) | April 26, 2018 | Dave Fornell
There have been a few big, recent advancements in cardiac computed tomography angiography (CCTA) imaging technology.
Siemens Healthineers, Florida Hospital Collaborate to Improve Healthcare Outcomes
News | CT Angiography (CTA) | January 23, 2018
January 23, 2018 – Siemens Healthineers and Florida Hospital, part of Adventist Health System, have announced a multi
Videos | CT Angiography (CTA) | July 21, 2017
DAIC and ITN Editor Dave Fornell discusses some of the most innovative new computed tomography (CT) technology and tr
Overlay Init